Christopher Nixon Cox

Insider Reports History

Location
Mountain View, CA
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Nixon Cox:

Company Role Class Num Shares Value Price $ Report Date Ownership
Alto Neuroscience, Inc. Director Stock Option (right to buy) 7,189 $84,973 $11.82 02 Jan 2026 Direct
Newsmax Inc. Director Option (Right to Buy) 17,500 28 Mar 2025 Direct

Insider Reports Filed by Christopher Nixon Cox

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANRO Alto Neuroscience, Inc. 02 Jan 2026 1 +$84,974 4 Director 06 Jan 2026, 16:47
ANRO Alto Neuroscience, Inc. 13 May 2025 1 $0 4 Director 15 May 2025, 16:16
NMAX Newsmax Inc. 28 Mar 2025 1 $0 4 Director 04 Apr 2025, 06:18
NMAX Newsmax Inc. 28 Mar 2025 0 $0 3 Director 28 Mar 2025, 15:47
ANRO Alto Neuroscience, Inc. 02 Jan 2025 1 +$79,998 4 Director 06 Jan 2025, 16:17
ANRO Alto Neuroscience, Inc. 06 Feb 2024 4 $0 4 Director 07 Feb 2024, 16:39
ANRO Alto Neuroscience, Inc. 01 Feb 2024 2 +$54,940 4 Director 05 Feb 2024, 16:42
ANRO Alto Neuroscience, Inc. 01 Feb 2024 0 $0 3 Director 01 Feb 2024, 18:47